Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Annals of Internal Medicine(2022)
Abstract
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
MoreTranslated text
Key words
opioid agonist therapy,risk behaviors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined